On Sep 30, 2021, the Arizona Business Innovation Awards, presented by Az Business magazine honored the 30 most innovative companies in Arizona. In addition to honoring the 30 most innovative companies in Arizona for 2021, the judges also selected five spotlight award winners for exceptional achievement.Continue reading
Author Archive: AZBio
Applications for the 2022 KEYS Internship Program Open Oct 1
The University of Arizona BIO5 Institute KEYS Research Internship recruitment for KEYS 2022 has officially begun!
Continue reading
Castle Biosciences President and CEO Derek Maetzold Will Deliver Keynote Presentation During Arizona Bioscience Week
Maetzold’s presentation will take place during the AZAdvances Life Science Innovation Showcase on October 6Continue reading
UArizona Cancer Center Researchers Identify Mechanism for Slowing Cancer Growth
Humabiologics becomes ISO 13485 Certified and GMP Compliant Manufacturer
The ISO 13485:2016 registration positions Humabiologics among the first global providers of GMP (Good Manufacturing Practices) grade human-derived biomaterials to support and expedite the future development of human regenerative therapies and tissue models for drug discovery through clinically relevant high-quality products. Continue reading
Are Innovations in Chemistry Your Thing? Apply to Present in the Scorpion Pit
RMRM 2021 Scorpion Pit Competition
Tucson Marriott University Park, Tucson, Arizona
Thursday, October 21, 2021 5:00 – 7:00 PMContinue reading
Ivy Brain Tumor Center and SonALAsense Announce Positive Initial Results of the First-in-Human Phase 0/1 Clinical Trial of Non-Invasive Sonodynamic Therapy for Recurrent Glioblastoma
Trial provides proof of concept for this new metabolically targeted, rapidly acting technology platform for brain tumors and other lethal cancersContinue reading
Here’s how the Arizona bioscience sector is pioneering innovations
The pace of medical innovation is accelerating around the world and right here in the Arizona bioscience sector. Biomedical innovators are pioneering in the fields of diagnostics, treatments, medical devices, and health technologies.Continue reading
DNA modifications could be used to determine the progression of severe liver disease
TGen-led study suggests that modifications of DNA at specific genomic sites correlate with levels of fibrosis in NAFLD and could be used to diagnose the severity of this conditionContinue reading
Roche opens access to pathology imaging tools to improve patient care
- Roche launches the Digital Pathology Open Environment, encouraging collaboration among software developers to improve patient outcomes and expand personalised healthcare through innovative image analysis tools
- Artificial intelligence technology shows promise in advancing pathology imaging, which can benefit cancer patients through more precise diagnosis leading to targeted treatment
- Open digital pathology environments can break down barriers to allow for rapid technology advances across industry and research partners, which is critical in developing next-generation diagnostic tests